BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21144625)

  • 1. CYP1A2-mediated biotransformation of cardioactive 2-thienylidene-3,4-methylenedioxybenzoylhydrazine (LASSBio-294) by rat liver microsomes and human recombinant CYP enzymes.
    Fraga AG; da Silva LL; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2011 Jan; 46(1):349-55. PubMed ID: 21144625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Cresteil T
    J Pharm Biomed Anal; 2010 Jul; 52(3):391-7. PubMed ID: 19804952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
    Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
    Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
    Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294.
    Carneiro EO; Andrade CH; Braga RC; Tôrres AC; Alves RO; Lião LM; Fraga CA; Barreiro EJ; de Oliveira V
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3734-6. PubMed ID: 20488703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro microsomal hepatic metabolism of antiasthmatic prototype LASSBio-448.
    Costa Nunes IK; Tinoco LW; Martins-Junior H; Rezende C; Barreiro EJ; Lima LM
    Curr Top Med Chem; 2014; 14(11):1388-98. PubMed ID: 24805061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of locomotor activity induced by the novel N-acylhydrazone derivatives LASSBio-785 and LASSBio-786 in mice.
    Silva GA; Kummerle AE; Antunes F; Fraga CA; Barreiro EJ; Zapata-Sudo G; Sudo RT
    Braz J Med Biol Res; 2013 Mar; 46(3):263-9. PubMed ID: 23558854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and vasodilatory activity of new N-acylhydrazone derivatives, designed as LASSBio-294 analogues.
    Silva AG; Zapata-Sudo G; Kummerle AE; Fraga CA; Barreiro EJ; Sudo RT
    Bioorg Med Chem; 2005 May; 13(10):3431-7. PubMed ID: 15848755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
    Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro.
    Wynalda MA; Hauer MJ; Wienkers LC
    Drug Metab Dispos; 1998 Oct; 26(10):1048-51. PubMed ID: 9763414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 2-amino-alpha-carboline. A food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2.
    Raza H; King RS; Squires RB; Guengerich FP; Miller DW; Freeman JP; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1996 Apr; 24(4):395-400. PubMed ID: 8801053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human cytochrome P450 enzymes involved in the metabolism of cyamemazine.
    Arbus C; Benyamina A; Llorca PM; Baylé F; Bromet N; Massiere F; Garay RP; Hameg A
    Eur J Pharm Sci; 2007 Dec; 32(4-5):357-66. PubMed ID: 17951033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP1A2 is the major isoform responsible for paeonol O-demethylation in human liver microsomes.
    Liu HX; Hu Y; Liu Y; He YQ; Li W; Yang L
    Xenobiotica; 2009 Sep; 39(9):672-9. PubMed ID: 19569730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of lithocholic acid by rat hepatic microsomes: metabolite analysis by liquid chromatography/mass spectrometry.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2008 Feb; 36(2):442-51. PubMed ID: 18039809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
    Kim H; Yoon YJ; Kim H; Kang S; Cheon HG; Yoo SE; Shin JG; Liu KH
    Toxicol Lett; 2006 Oct; 166(2):105-14. PubMed ID: 16857327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
    Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
    Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.